Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e1ac9096a46b26c78e369e5507f95bf |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70567 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2001-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fccd27cf05e600bc81eacb9da6263f4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06e7b0bcb73460d9d537944114693a1a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0db8e08df103a103f0f8bc59f526799 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eb4104563b8cb4183b4904337bd1954 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1f61fb3b73aaac28e76f5e1df49fc3d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c7de6d1763e3189b869b61f924133d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_684ab62097c9464ac50d801e04f187cf |
publicationDate |
2002-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2420932-A1 |
titleOfInvention |
Novel mammalian nuclear receptor l66 and methods of use |
abstract |
The present invention relates to a novel nuclear receptor called "L66" or al so FXR-.beta. a homologue of the FXR-.alpha., a prototypical type 2 nuclear receptor. The invention also relates to the isolated nucleic acid sequence o f L66 and the isolated protein thereof. The invention further relates to processes for isolating and/or producing the nucleic acid or the protein as well as methods of use of the receptor L66. |
priorityDate |
2000-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |